Top compounds associated with response to FRMPD4


Feature Type Standardized
Nominal ANOVA
mRNA YM-155 CTRPv2 pan-cancer AAC -0.054 0.2
mRNA narciclasine CTRPv2 pan-cancer AAC -0.047 0.2
mRNA Nilotinib CCLE pan-cancer AAC -0.07 0.2
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.05 0.2
mRNA Sorafenib GDSC1000 pan-cancer AAC -0.074 0.2
mRNA Pazopanib GDSC1000 pan-cancer AAC 0.047 0.2
mRNA ifosfamide CTRPv2 pan-cancer AAC -0.074 0.2
mRNA BRD-K33199242 CTRPv2 pan-cancer AAC 0.052 0.2
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC 0.05 0.2
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.046 0.2
Download CSV